AOL Money & Finance

Intuitive Surgical jumps over 32% - where's the ceiling?

More

Today was an amazing day for shareholders of Intuitive Surgical (NASDAQ: ISRG) which closed up $48.51 (32.32%) to $198.59. This fete was accomplished on a dour day in the stock market when most companies watched share prices drop. The ISRG bounce followed a spectacular earnings report Thursday July 19: Intuitive Surgical Announces $140.2 Million Second Quarter Revenue, Up 61 Percent; Net Income Increases 84 Percent

This stock is the only stock I own that is a pure play growth story and the metrics are wild. I cannot really advise anyone what a fair price would be, because I do not know. About the only thing you can do with a stock like this is try to build a position on pull backs, but there have not been many lately.

I have written about ISRG many times and I have had many friends that bought shares at much lower prices ask me what might stop this company or stock and the answer is -- "I don't know". I know why I bought it. I know the reasons I bought it remain intact, if not even more secure now then ever.

Briefly, ISRG makes equipment for robotic assisted surgical procedures, and the software, spare parts, scheduled replacement parts, with follow on contracts for software upgrades, maintenance and service. They offer hospitals a comprehensive contract for everything, and hold most of the patents. Warren Buffett often talks about huge moats for protection of stock value.

How's this for a moat: if you and I had unlimited financial resources, and the medical, scientific, and engineering expertise to create a better product and range of services at a lower price, how many years would it take to develop? When we were ready after these efforts and the appropriate medical and legal wrangling we applied for patents and FDA approval how long would that take to accomplish? So even with all the resources in the universe I think that it would take an eternity trying to catch up, and at a tremendous expense.

Intuitive Surgical is still inventing, expanding, selling, patenting and increasing the types of approved procedures, all the while adding surgical units in hospitals around the world to it's customer base. I have no idea where the ceiling for this stock is but we are not there yet.

Those of you who are new to BloggingStocks can check out my other stories and read Chasing Value or Serious Money to find more potential opportunities and verify my track record as well.

Sheldon Liber is the CEO of a small private investment company and the principal for design and research at an architecture & planning firm.

Symbol Lookup
IndexesChangePrice
DJIA-14.2810,318.16
NASDAQ-10.782,146.04
S&P 500-3.521,091.38

Last updated: November 22, 2009: 05:11 AM

BloggingStocks Exclusives

Hot Stocks

DailyFinance Headlines

Latest from BloggingBuyouts

TheFlyOnTheWall.com Headlines

    BioHealth Investor Headlines

    WalletPop Headlines

    My Portfolios

    Track your stocks here!

    Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

    BloggingStocks Partners

    More from AOL Money & Finance

    WalletPop Headlines